Wednesday, September 16, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Robert Lin, MD
practices
New Mexico Cancer Center
Published Articles (1)
The New Frontier in Lung Cancer Therapy: Targeted Therapy, and Bispecific Antibodies.
September 14, 2026
Adjuvant targeted therapy already has a track record in early-stage non-small cell lung cancer (NSCLC) driven by EGFR or ALK alterations, where it has meaningfully reduced recurrence after surgery.